Urofollitropin or follicle-stimulating hormone (FSH) is a fertility drug that is used to induce ovulation in women struggling with infertility. This medication is designed to mimic the action of the natural hormone FSH, which plays a critical role in the female reproductive system by promoting the growth and maturation of ovarian follicles that contain eggs.
If you are considering using urofollitropin, here are a few things you should know:
1. How It Works
Urofollitropin acts on the pituitary gland in the brain, triggering the release of FSH and luteinizing hormone (LH). This results in the growth and development of ovarian follicles, which eventually release mature eggs that can be fertilized.
2. Who It's For
Urofollitropin is typically prescribed for women who are struggling with ovulation disorders such as polycystic ovary syndrome (PCOS) or primary ovarian insufficiency (POI). It may also be used in conjunction with other fertility drugs to stimulate the ovaries in women undergoing in vitro fertilization (IVF) or other assisted reproductive technologies (ART).
3. How It's Administered
Urofollitropin is administered by injection and is typically given for 7 to 12 days during the menstrual cycle. The dosage and duration of treatment will depend on the individual's specific condition and response to the medication.
4. Potential Side Effects
Like any medication, urofollitropin may cause side effects, although these are usually mild and temporary. The most common side effects include headache, abdominal pain, bloating, and nausea. More serious complications such as ovarian hyperstimulation syndrome (OHSS) may occur in rare cases.
5. Success Rates
When used in conjunction with other fertility medications, urofollitropin has been found to be effective in inducing ovulation and increasing the chances of pregnancy. Studies have shown that up to 90% of women with PCOS who undergo treatment with urofollitropin and other fertility drugs are able to ovulate and achieve pregnancy.